Insider Transactions in Q2 2022 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,620
+2.96%
|
$16,200
$10.9 P/Share
|
|
Jun 30
2022
|
Jeffrey Trigilio Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,451
+3.4%
|
$14,510
$10.9 P/Share
|
|
Jun 30
2022
|
Nadim Ahmed President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,620
+14.3%
|
$16,200
$10.9 P/Share
|
|
Jun 24
2022
|
Morana Jovan Embiricos > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
45,078
-17.83%
|
$586,014
$13.39 P/Share
|
|
Jun 24
2022
|
Morana Jovan Embiricos > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
140,374
+22.43%
|
$561,496
$4.3 P/Share
|
|
Jun 23
2022
|
F2 Bioscience I 2017 LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
29,631
-5.23%
|
$385,203
$13.0 P/Share
|
|
Jun 22
2022
|
F2 Bioscience I 2017 LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
49,953
-8.1%
|
$599,436
$12.7 P/Share
|
|
Jun 21
2022
|
F2 Bioscience I 2017 LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
22,319
-3.49%
|
$267,828
$12.77 P/Share
|
|
Jun 06
2022
|
Nadim Ahmed President and CEO |
BUY
Open market or private purchase
|
Direct |
8,090
+50.0%
|
$97,080
$12.4 P/Share
|
|
Jun 01
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
751,396
+9.72%
|
$8,265,356
$11.0 P/Share
|
|
May 16
2022
|
Vision Scs F2 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
35,158
-2.62%
|
$386,738
$11.23 P/Share
|
|
May 13
2022
|
Vision Scs F2 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
119,508
-4.16%
|
$1,195,080
$10.22 P/Share
|
|
May 13
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
109,900
+2.71%
|
$989,100
$9.13 P/Share
|
|
May 12
2022
|
Vision Scs F2 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
264,072
-15.31%
|
$2,376,648
$9.25 P/Share
|
|
May 12
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000,000
+13.9%
|
$9,000,000
$9.06 P/Share
|
|
Apr 01
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
276,000
+4.22%
|
$2,760,000
$10.75 P/Share
|